Market Structure, Emerging Trends, and Key Player Analysis in the Orthobiologics Devices and Equipment Sector

The orthobiologics devices and equipment market is set to experience notable expansion in the coming years, driven by advancements in medical technology and changing healthcare demands. This sector is evolving rapidly, fueled by innovations and an increasing need for effective orthopedic treatments, highlighting its promising future.

Forecasted Market Value and Growth Rate of Orthobiologics Devices and Equipment
The market size for orthobiologics devices and equipment is projected to reach $8.64 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.0%. This robust growth is expected due to factors such as an aging global population, breakthroughs in regenerative medicine, rising demand for minimally invasive procedures, expanded reimbursement policies, and ongoing technological enhancements in biomaterials. Key trends anticipated throughout this period include wider adoption of regenerative therapies, increased treatment of sports-related injuries, greater utilization of stem cell-based products, a preference for non-surgical orthopedic options, and the growing number of orthopedic clinics worldwide.

Download a free sample of the orthobiologics devices and equipment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2568&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Key Industry Leaders in the Orthobiologics Devices and Equipment Market
Several prominent companies play a significant role in shaping the orthobiologics devices and equipment industry. These include BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, and Bone Biologics Corp.

Notable Acquisition Enhancing Market Position
In January 2023, Zimmer Biomet Holdings Inc., a US-based medical technology firm, acquired Embody Inc. for an undisclosed amount. This strategic acquisition aims to bolster Zimmer Biomet's growing sports medicine portfolio by incorporating Embody's cutting-edge soft tissue healing solutions. Embody Inc. specializes in collagen-based soft-tissue regeneration implants, which complement the orthobiologics devices and equipment market and support Zimmer Biomet's long-term transformation goals.

View the full orthobiologics devices and equipment market report:
https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Innovative Trends Transforming the Orthobiologics Devices and Equipment Sector
Leading companies are investing in the development of new regenerative technologies to improve patient outcomes. One area of focus is synthetic bone fusion gels, which serve as biomaterial scaffolds and delivery systems for growth factors, encouraging bone regeneration in spinal fusion and orthopedic surgeries.

A prime example occurred in January 2024 when Renovos Biologics Ltd., a UK biomaterial company backed by Biocomposites, secured FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel called Renovite BMP-2. This injectable and moldable gel is engineered to hold bone morphogenetic protein-2 (BMP-2) precisely at surgical sites, promoting efficient bone healing while reducing risks like unwanted bone growth and soft-tissue complications seen with older carrier methods. This innovation aims to enable a more controlled and effective fusion process.

Comprehensive Segmentation of the Orthobiologics Devices and Equipment Market
The orthobiologics devices and equipment market is categorized based on several segments to provide a detailed view of the industry:
1) Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics
2) Application Areas: Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery
3) End Use: Hospitals, Orthopedic Clinics, Other End Users

Further detailed subsegments include:
- Demineralized Bone Matrix: Injectable forms, pastes and putties, scaffolds
- Synthetic Bone Substitutes: Calcium phosphate ceramics, bioactive glasses, polymers and composites
- Stem Cell Therapy: Products derived from adipose tissue, bone marrow, and umbilical cord blood
- Plasma-Rich Protein: Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) products
- Viscosupplementation: Hyaluronic acid injections and combination products
- Bone Morphogenetic Protein (BMP): Recombinant BMPs and delivery systems
- Synthetic Orthobiologics: Growth factor-enhanced products, biodegradable scaffolds with bioactive agents, and other synthetic formulations

This detailed segmentation aids in understanding the diverse product offerings, applications, and user bases within the orthobiologics devices and equipment market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.